Revenue
2010
2011
2019
2020
2021
2022
2023
2024
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 · Apr 30 | 2008 · Mar 30 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $16,303 | $19,235 | $12,972 | $23,761 | $10,622 | $14,000 | — | — | — | — | — | — | — | $0 | $0 | — | — | — |
| Research & development | $574,755 | $490,162 | $325,156 | $172,877 | $439,816 | $463,468 | $444,002 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $2.6M | $3.4M | $3.1M | $2.4M | $2.4M | $2.7M | $2.1M | $1.0M | $733,184 | $674,936 | $1.1M | $1.2M | $1.9M | $693,783 | $1.1M | $798,147 | — | — | — |
| Operating income | −$2.6M | −$3.3M | −$3.1M | −$2.4M | −$2.3M | −$2.7M | −$2.1M | −$1.0M | −$733,184 | −$674,936 | −$1.1M | −$1.2M | — | — | — | — | — | — | — |
| EBITDAderived | −$2.5M | −$3.3M | −$3.0M | −$2.4M | −$2.3M | −$2.7M | −$2.0M | −$1.0M | −$699,200 | −$640,952 | −$1.0M | −$1.1M | — | — | — | — | — | — | — |
| Net income | −$2.7M | −$3.9M | −$3.2M | −$2.6M | −$2.6M | −$2.7M | −$2.3M | −$1.3M | −$999,847 | −$1.4M | −$1.2M | −$2.2M | −$2.2M | −$956,798 | −$1.5M | −$1.0M | −$1.1M | −$282,364 | −$282,364 |
| Basic EPSper diluted share | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |
| Diluted EPSper diluted share | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 6, 2026Form 4 | Kennedy KyleCEO | BuyCommon Stock | 12.00M | $0.00 | $0.00 | 12.00M |